What is the management plan for a patient with moderate mitral valve regurgitation, Grade I diastolic dysfunction, normal ejection fraction (EF), and no evidence of left ventricular hypertrophy (LVH) or aortic root dilatation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for Moderate Mitral Regurgitation with Grade I Diastolic Dysfunction

The appropriate ICD-10 code is I34.0 (Nonrheumatic mitral [valve] insufficiency).

Primary Diagnosis Code

  • I34.0 is the specific code for nonrheumatic mitral valve regurgitation/insufficiency, which applies to this patient with moderate mitral regurgitation 1

Additional Relevant Codes to Consider

  • I50.32 (Chronic diastolic [congestive] heart failure) may be considered given the Grade I diastolic dysfunction, though this represents impaired relaxation rather than overt heart failure 1
  • If the patient has any symptoms of heart failure, I50.9 (Heart failure, unspecified) could be added as a secondary code 1

Management Approach for This Clinical Scenario

Surveillance Strategy

This patient requires regular echocardiographic monitoring every 1-2 years given the moderate mitral regurgitation with normal ejection fraction 1, 2. More frequent monitoring (every 6-12 months) should be implemented if there are dynamic changes or parameters approaching intervention thresholds 1, 2.

Key parameters to monitor include:

  • Left ventricular ejection fraction and end-systolic dimension (LVESD) 1
  • Left atrial volume index (threshold ≥60 mL/m²) 1, 2
  • Development of new atrial fibrillation 1
  • Pulmonary artery systolic pressure (threshold ≥50 mmHg) 1, 2
  • Progressive LV dilation on serial imaging 1

Current Management Recommendations

No surgical intervention is indicated at this time 2. The patient has moderate (not severe) MR with preserved LVEF (60-65%) and normal LV size without evidence of LVH 1, 2.

Medical management considerations:

  • No specific medical therapy is required for asymptomatic moderate MR with preserved LVEF 2
  • If hypertension is present, aggressive blood pressure control is essential as it can affect MR severity 2
  • The Grade I diastolic dysfunction does not require specific treatment beyond standard cardiovascular risk factor management 1

Critical Thresholds for Surgical Referral

Immediate surgical evaluation becomes necessary if any of the following develop 1, 2:

  • Progression to severe MR with symptoms (NYHA Class II-IV) 1
  • LVEF decreases to <60% with LVESD ≥40 mm 1, 2
  • New-onset atrial fibrillation secondary to MR 1, 2
  • Resting pulmonary artery systolic pressure exceeding 50 mmHg 1, 2
  • LA volume index reaching ≥60 mL/m² 1, 2

Important Clinical Caveats

The normal ejection fraction of 60-65% should not provide false reassurance 2. In the context of mitral regurgitation, EF is typically augmented by the low-impedance pathway into the left atrium, so an EF at the lower end of normal (60%) may actually reflect early ventricular dysfunction 2.

Regular surveillance is crucial as moderate MR can progress to severe MR over time 2. Serial imaging demonstrating progressive changes should prompt earlier referral even in asymptomatic patients 1, 2.

Special Consideration for Concomitant Surgery

If this patient requires cardiac surgery for another indication (e.g., coronary artery bypass grafting), concomitant mitral valve repair may be considered even for moderate MR 1, 2. This is a Class IIa recommendation when performed at experienced centers 1.

Preferred Intervention When Needed

When intervention eventually becomes necessary, mitral valve repair is strongly preferred over replacement 1, 2. Repair preserves LV function, avoids prosthetic valve complications, and improves long-term outcomes compared to replacement 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Moderate Mitral Regurgitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next best step in managing a patient with low-normal left ventricular systolic function and trace/mild valvular regurgitation?
What is the next best treatment plan for a 70-year-old female with hyperdynamic LVEF, concentric LVH, mildly dilated LA, mild to moderate mitral regurgitation, and normal filling pressure?
What is the optimal management plan for an elderly patient with new onset atrial fibrillation, heart failure with mid-range ejection fraction, and moderate to severe mitral regurgitation?
What is the management approach for a patient with moderate mitral regurgitation (MR) with an eccentric jet and a left ventricular ejection fraction (LVEF) of mildly reduced left ventricular function?
What is the recommended management for a patient with moderate concentric left ventricular hypertrophy, low normal left ventricular systolic function, and evidence of diastolic dysfunction, with additional findings of mild valvular aortic stenosis and mitral regurgitation?
What are the guidelines for using diazepam (Diazepam) nasal spray in patients with acute repetitive seizures or severe anxiety?
What are the considerations for using Ativan (lorazepam) on a pro re nata (PRN) basis for a geriatric patient with dementia?
Is 40mg of Paxil (paroxetine) a suitable dose for a geriatric patient with potentially impaired renal function?
Can a higher dose of Qelbree (viloxazine) increase anxiety or improve mood regulation in a patient with Attention Deficit Hyperactivity Disorder (ADHD) and a history of anxiety symptoms?
Is a single-time PET (Positron Emission Tomography) CT scan necessary for detecting hidden metastasis in a patient with a history of hepatocellular carcinoma (HCC) after undergoing hepatectomy?
What are the parameters for prescribing midodrine (alpha-1 adrenergic receptor agonist) to an older adult patient with orthostatic hypotension, possibly with a history of diabetes, Parkinson's disease, or impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.